Herbalife & ephedra
This article was originally published in The Tan Sheet
Executive Summary
Direct marketer's plans to discontinue sales of ephedrine alkaloid-containing supplements have been indefinitely delayed due to management's intensive work on proposed acquisition to take the company private, delays in finalizing plans for new product launch, company says. Herbalife originally was slated to halt sales of such products by June 1, according to Morgan Stanley's fairness evaluation of the going-private transaction (1"The Tan Sheet" June 17, 2002, p. 5). Shareholder vote on proposed acquisition by Whitney & Co., Golden Gate Capital is expected in late July...